Novo Nordisk A/S (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 77   

Articles published

NVO 45.12 -0.28 (-0.62%)
price chart
Momentum Stocks in Focus - Novo Nordisk A/S (ADR)(NYSE:NVO), XOMA Corp ...
Las Vegas, NV - 19 July, 2014 - (TechSonian) �EquityObserver.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
Watch List: Lannett Company (NYSE:LCI), Novo Nordisk A/S (ADR) (NYSE:NVO ...
On June 25, 2014, Novo Nordisk A/S (ADR) (NYSE:NVO), is teaming up with NBA great and Hall of Famer Dominique Wilkins to launch Dominique's Diabetes Dream Team, a national initiative to help adults with type 2 diabetes customize a full-court approach ...
Related articles »  
Notable Stocks: MEI Pharma Inc (NASDAQ:MEIP), Dr. Reddy's Laboratories ...
On June 23, Novo Nordisk A/S (ADR) (NYSE:NVO) Victoza (liraglutide 3 mg) showed statistically significant results in the randomized, placebo-controlled, double-blind, phase IIIa SCALE Diabetes study (n=846) for chronic weight management.
Related articles »  
Trader's recap: Teva Pharmaceutical Industries (NYSE:TEVA), Amarin ...
On last trading day Novo Nordisk A/S (ADR) (NYSE:NVO) ended up 0.22% higher to close at $45.53 while trading in the range of $45.13 - $45.58.
Related articles »  
Drug Manufacturers: Synergy Pharmaceuticals Inc (NASDAQ:SGYP), Prana ...
On 1 JULY Novo Nordisk A/S (ADR) (NYSE:NVO) initiated a share repurchase programme in accordance with the provisions of the European Commission's regulation no 2273/2003 of 22 December 2003, also referred to as the Safe Harbour rules.
Related articles »  
MannKind Corporation (NASDAQ:MNKD) Surged 9.60%: Furiex ...
On June 25, Novo Nordisk A/S (ADR) (NYSE:NVO) is teaming up with NBA great and Hall of Famer Dominique Wilkins to launch Dominique's Diabetes Dream Team, a national initiative to help adults with type 2 diabetes customize a full-court approach to ...
Stocks to Track: Auxilium Pharmaceuticals, Inc. (AUXL), Tenet Healthcare Corp ...
Novo Nordisk A/S (ADR)(NYSE:NVO) engages in the discovery, development, manufacture, and marketing of pharmaceutical products primarily in Denmark.
Novo Nordisk A/S: Share repurchase programme
Headquartered in Denmark, Novo Nordisk employs approximately. 40,000 employees in 75 countries, and markets its products in more than 180 countries.
MannKind Surging On AFREZZA Approval
MannKind Corporation (MNKD) revealed on Friday that the Food and Drug Administration (FDA) approved its inhaled insulin, AFREZZA, used for improving glycemic control caused by diabetes mellitus in adult patients.
Related articles »